Gbenga Kazeem
About
Gbenga Kazeem is a scholar working on Surgery, Transplantation and Infectious Diseases.
According to data from OpenAlex, Gbenga Kazeem has authored 32 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Transplantation and 7 papers in Infectious Diseases. Recurrent topics in Gbenga Kazeem's work include Renal Transplantation Outcomes and Treatments (12 papers), Organ Transplantation Techniques and Outcomes (9 papers) and Clostridium difficile and Clostridium perfringens research (6 papers). Gbenga Kazeem is often cited by papers focused on Renal Transplantation Outcomes and Treatments (12 papers), Organ Transplantation Techniques and Outcomes (9 papers) and Clostridium difficile and Clostridium perfringens research (6 papers). Gbenga Kazeem collaborates with scholars based in United Kingdom, Germany and Italy. Gbenga Kazeem's co-authors include Martin Farrall, Oliver A. Cornely, Andreas Karas, Benoît Guéry, Maria J. G. T. Vehreschild, Andrew C. Nelsen, Charles Cox, Matthew R. Nelson, John A. Messenheimer and José Palacios and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes and Journal of the American Society of Nephrology.
In The Last Decade
Gbenga Kazeem
32 papers receiving 748 citations
Peers
Gbenga Kazeem
Keevin Bernstein Canada
Varvara A. Kirchner United States
Surasak Kantachuvesiri Thailand
Jeannine M. Heckmann South Africa
Heike Goebel Germany
Juthaporn Cowan Canada
Veronica Resi Italy
Maria Rosa Costanzo‐Nordin United States
Rajni Agarwal United States
Séverine Beaudreuil France
Citations per year, relative to Gbenga Kazeem Gbenga Kazeem (= 1×)
peers
Keevin Bernstein
Countries citing papers authored by Gbenga Kazeem
Since
Specialization
Citations
This map shows the geographic impact of Gbenga Kazeem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gbenga Kazeem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gbenga Kazeem more than expected).
Fields of papers citing papers by Gbenga Kazeem
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Gbenga Kazeem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gbenga Kazeem. The network helps show where Gbenga Kazeem may publish in the future.
Co-authorship network of co-authors of Gbenga Kazeem
This figure shows the co-authorship network connecting the top 25 collaborators of Gbenga Kazeem. A scholar is included among the top collaborators of Gbenga Kazeem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gbenga Kazeem. Gbenga Kazeem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Dyachkova, Yulia, Cornelia Dunger‐Baldauf, Nathalie Barbier, et al.. (2024). Do You Want to Stay Single? Considerations on Single‐Arm Trials in Drug Development and the Postregulatory Space. Pharmaceutical Statistics. 23(6). 1206–1217.
2.
Mateos, María‐Victoria, Paweł Robak, Marek Hus, et al.. (2024). DREAMM-7 update: Subgroup analyses from a phase 3 trial of belantamab mafodotin (belamaf) + bortezomib and dexamethasone (BVd) vs daratumumab, bortezomib, and dexamethasone (DVd) in relapsed/refractory multiple myeloma (RRMM).. Journal of Clinical Oncology. 42(16_suppl). 7503–7503.
3.
Ng, Alvin Wei Tian, et al.. (2023). Impact of neurofibromatosis type 1 with plexiform neurofibromas on the health-related quality of life and work productivity of adult patients and caregivers in the UK: a cross-sectional survey. BMC Neurology. 23(1). 419–419.
4.
Alt, Marie, et al.. (2023). Identification of characteristics predictive of long-term survival with durvalumab or durvalumab plus tremelimumab in metastatic urothelial carcinoma. BMC Cancer. 23(1). 919–919.
5.
Pernin, Vincent, Maciej Głyda, Ondřej Viklický, et al.. (2023). Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study. Transplantation Direct. 9(3). e1432–e1432.
6.
Friman, Styrbjörn, Giuseppe Tisone, Frederik Nevens, et al.. (2021). Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study. Transplantation Direct. 7(8). e722–e722.
7.
Rubik, Jacek, Dominique Debray, Déirdre Kelly, et al.. (2019). Efficacy and safety of prolonged‐release tacrolimus in stable pediatric allograft recipients converted from immediate‐release tacrolimus – a Phase 2, open‐label, single‐arm, one‐way crossover study. Transplant International. 32(11). 1182–1193.
8.
Rubik, Jacek, Dominique Debray, Franck Iserin, et al.. (2019). Comparative pharmacokinetics of tacrolimus in stable pediatric allograft recipients converted from immediate‐release tacrolimus to prolonged‐release tacrolimus formulation. Pediatric Transplantation. 23(4). e13391–e13391.
9.
Vondrák, Karel, Francesco Parisi, Anil Dhawan, et al.. (2019). Efficacy and safety of tacrolimus in de novo pediatric transplant recipients randomized to receive immediate‐ or prolonged‐release tacrolimus. Clinical Transplantation. 33(10). e13698–e13698.
10.
Cornely, Oliver A., et al.. (2019). Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection: EXTEND study subgroup analyses. European Journal of Clinical Microbiology & Infectious Diseases. 38(6). 1187–1194.
11.
Vondrák, Karel, Anil Dhawan, Francesco Parisi, et al.. (2018). Comparative pharmacokinetics of tacrolimus in de novo pediatric transplant recipients randomized to receive immediate‐ or prolonged‐release tacrolimus. Pediatric Transplantation. 22(8). e13289–e13289.
12.
Guéry, Benoît, Francesco Menichetti, Veli-Jukka Anttila, et al.. (2017). Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial. The Lancet Infectious Diseases. 18(3). 296–307.
13.
Tisone, Giuseppe, Nasrullah Undre, Gbenga Kazeem, et al.. (2016). Renal function outcomes with prolonged-release tacrolimus according to donor age after de novo liver transplantation: a post hoc analysis from the diamond randomized, controlled trial. Transplantation. 100.
14.
Mourad, Georges, Maciej Głyda, Laetitia Albano, et al.. (2016). Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies. Transplantation. 101(8). 1924–1934.
15.
Mastro, Lucia Del, Alessandra Fabi, Mauro Mansutti, et al.. (2013). Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments. BMC Cancer. 13(1). 164–164.
16.
Kazeem, Gbenga, Charles Cox, Jennifer L. Aponte, et al.. (2009). High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenetics and Genomics. 19(9). 661–665.
17.
Hadjadj, Samy, Lise Tarnow, Carol Forsblom, et al.. (2007). Association between Angiotensin-Converting Enzyme Gene Polymorphisms and Diabetic Nephropathy. Journal of the American Society of Nephrology. 18(4). 1284–1291.
18.
Kazeem, Gbenga & Martin Farrall. (2005). Integrating Case-control and TDT Studies. Annals of Human Genetics. 69(3). 329–335.
19.
Kazeem, Gbenga & Martin Farrall. (2005). Integrating Case‐control and TDT Studies. Annals of Human Genetics. 69(3). 329–335.
20.
García, Edwin, Elizabeth Taylor, Huimin Wu, et al.. (2004). Haplotypes of the ??2-adrenergic receptor gene are associated with essential hypertension in a Singaporean Chinese population. Journal of Hypertension. 22(11). 2111–2116.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Keevin Bernstein Breakdown of academic impact, for papers by Varvara A. Kirchner Breakdown of academic impact, for papers by Surasak Kantachuvesiri Breakdown of academic impact, for papers by Jeannine M. Heckmann Breakdown of academic impact, for papers by Heike Goebel Breakdown of academic impact, for papers by Juthaporn Cowan Breakdown of academic impact, for papers by Veronica Resi Breakdown of academic impact, for papers by Maria Rosa Costanzo‐Nordin Breakdown of academic impact, for papers by Rajni Agarwal Breakdown of academic impact, for papers by Séverine Beaudreuil